the Company’s net sales grew by 11.86%

PT Enseval Putera Megatrading Tbk Net Sales, 11.86% OF GROWING AT THE END OF QUARTER III 2014

Press Release No.003 / EPM / CSEC / X / 2014

Jakarta, October 31, 2014 – According to the Consolidated Financial Statements of PT Enseval Putera Megatrading Tbk and Subsidiaries (the “Company”) September 30, 2014 and For the Period Ended (Unaudited), the Company hereby informs that at the end of the third quarter of 2014, the Company’s net sales grew by 11.86% when compared with net sales at the end of the third quarter of 2013.

The net sales of the Company on 30 September 2014 stood at Rp12.479,94 billion, compared with net sales in the same period in 2013 which was recorded at Rp11.156,6 billion. While the profit of the current year on the 30th of September 2014 stood at Rp355,04 billion, an increase of 22.34% when compared to the current year’s profits in the same period in 2013 which was recorded at Rp290.21 billion.

Our success suppress the increase in cost of sales in order to remain below the percentage increase in net sales of the Company, resulting in an increase in gross profit. Gross profit of the Company on 30 September 2014 stood at Rp1.397,55 billion, an increase of 13.61% compared to gross profit in the same period in 2013 which was recorded at Rp1.230,16 billion. While the cost of sales of the Company on 30 September 2014 stood at Rp11.082,39 billion, an increase of 11.65%, slightly lower than the increase in net sales.

The operating expenses of the Company on 30 September 2014 has increased. Operating expenses on 30 September 2014 stood at Rp938,86 billion, an increase of 13.2% compared to operating expenses in the same period in 2013 which was recorded at Rp829,35 billion. The Company’s operating expenses increased due to an increase in selling expenses of the Company. The increase in selling expenses due to the Company’s two (2) major component in selling expenses increased significantly. The second major component is that component costs of salaries, wages and employee benefits and components of the transportation and shipping costs. Component costs of salaries, wages and employee benefits increased by 20.55%. While the components of the transport and delivery costs increased by 8.17%. Operating Expenses of the Company at the end of the third quarter of 2014 consisted of selling expenses amounted Rp798,04 billion and general and administrative expenses amounted to Rp140,82 billion.

From the comparison of the Consolidated Statements of Financial Position of the Company until the date of 30 September 2014 (Unaudited) Consolidated Statements of Financial Position with the Company until the date of December 31, 2013 (Unaudited), the Company’s total assets increased from Rp5.53 trillion to Rp6,01 trillion or an increase amounted to 8.63%. Total liabilities of the Company increased by 4.91% from Rp2,49 trillion by the end of 2013 became Rp2,61 trillion by the end of the third quarter of 2014. Shareholders’ equity increased by 11.68% from Rp3,04 trillion trillion to Rp3,39 .

Each Performance – Each Division

The Company has six Division, which consists of the Division of Consumer Goods, Prescription Drug, Drug Free, Raw Materials For Sale, Medical Equipment, Animals & Livestock Medicines and Health Care Services.

As for the details rather than the performance of each division of the Company can be described as follows:
• Consumer Goods Division, the division with the highest contribution to the total net sales, which amounted to 44.91%. At the end of the third quarter of 2014, the division recorded a net sales grew by Rp5.605,28 billion or 14.94% when compared to the same period in 2013.
• Prescription Drug Division, contributed the second largest after the Division of Consumer Goods with a contribution of 28.29%. On September 30, 2014, Prescription Drug Division recorded a net sales amounted Rp3.530,57 billion, growing by 10.75% when compared to the same period in 2013.
• Free Drugs Division, managed to record net sales of Rp1.935,48 billion at the end of the third quarter of 2014 with a contribution of 15.51%, and a growth of 7.91% compared to the same period in 2013.
• Division of Raw Materials For Sale recorded net sales of Rp980,42 billion at the end of the third quarter of 2014, an increase of 24.8% over the same period in 2013, and accounted for 7.86%.
• Medical Equipment Division contributed 3.12% at the end of the third quarter of 2014, with net sales figure stood at Rp389,36 billion, a decrease of 18.72% compared to the same period in 2013.
• The net sales of the Pharmaceuticals Division totaled Animals and Livestock Rp34,81 billion, an increase of 12.28% compared to the same period in 2013, which amounted to Rp31 billion. Division of Animal Medicine and Livestock contributes 0.28% of the Company’s total net sales.
• Although still a small contribution, Health Care Services Division again experienced net sales growth. At the end of the third quarter of 2014, net sales of this division amounted Rp4,03 billion, an increase of 34.64% compared to the same period in 2013, which amounted to 3 billion. This division contributes to the total net sales of the Company is 0.03%.

About Enseval

Enseval is the largest distribution company in Indonesia which has commenced distribution since 1973 and has more than 7,000 employees. Company Enseval be open on August 1, 1994 under the name PT Enseval Son Megatrading Tbk (IDX: EPMT). In addition to distributing the products of Kalbe Group, Enseval also trusted by the principal-other principals from both inside and outside the country. The company has a wide distribution network with 2 Regional Distribution Center (RDC) located in Jakarta and Surabaya and 45 branches spread throughout the islands of Indonesia and 24 other branches through its subsidiaries, PT Tri Sapta Jaya. To date, the Company has five Subsidiaries, which is engaged in the distribution, raw materials, medical equipment and health service.

Jakarta, October 31, 2014

Baca Juga

EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS 2017, CHANGE OF COMPANIES BOARD OF DIRECTORS

November 30, 2017

Jakarta, 30 November 2017 – PT Enseval Putera Megatrading Tbk (“The Company”) has convened an Extraordinary General Meeting of Shareholders (EGM), held in EPM Function Room, Building A Floor II, Jalan Rawa Gelam IV Number 6, Pulogadung Industrial Estate , East Jakarta, with an agenda that is Changes in the composition of the directors of the Company.

Read More

Changes in the composition of the Board of Commissioners, Audit Committee, Nomination & Remuneration Committee.

March 5, 2018

PT Enseval Putera Megatrading Tbk (the Company) with deep condolence, submitted the change of the composition of the Board of Commissioners, the Audit Committee, and the Nomination & Remuneration Committee in connection with the death of Mr. J.B. Apik Ibrahim as Independent Commissioner, Chairman of the Audit Committee and Chairman of the Company’s Nomination and Remuneration Committee on Thursday, March 1, 2018.

Read More